Evoke Pharma, Inc. (EVOK)
USD 3.09
(6.19%)
USD 3.09
(6.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.18 Million | 2.5 Million | 1.61 Million | 23.02 Thousand | - | - |
| Cost of Revenue | 201.87 Thousand | 370.39 Thousand | 328.11 Thousand | 86.71 Thousand | - | - |
| Gross Profit | 4.97 Million | 2.13 Million | 1.28 Million | -63.69 Thousand | - | - |
| Operating Expenses | 12.4 Million | 9.92 Million | 9.44 Million | 12.98 Million | 7.15 Million | 8.01 Million |
| Selling, General and Administrative Expenses | 12.22 Million | 9.62 Million | 8.85 Million | 6.42 Million | 3.73 Million | 3.91 Million |
| Research and Development Expenses | 181.9 Thousand | 300.78 Thousand | 590.47 Thousand | 6.55 Million | 3.41 Million | 4.09 Million |
| Other Expenses | - | 370.39 Thousand | 328.11 Thousand | 86.71 Thousand | - | - |
| Cost and Expenses | 12.61 Million | 10.29 Million | 9.76 Million | 13.07 Million | 7.15 Million | 8.01 Million |
| Operating Income | -7.43 Million | -7.78 Million | -8.15 Million | -13.04 Million | -7.15 Million | -8.01 Million |
| Interest Expense | 500 Thousand | 500 Thousand | 500.05 Thousand | 112.99 Thousand | - | 15.21 Thousand |
| Income Tax Expense | - | -62 Thousand | 491.43 Thousand | 107.32 Thousand | -28.79 Thousand | -912.42 Thousand |
| Earnings before Tax | -7.79 Million | -8.22 Million | -8.53 Million | -13.15 Million | -7.12 Million | -7.56 Million |
| Net Income | -7.79 Million | -8.16 Million | -9.02 Million | -13.26 Million | -7.09 Million | -7.56 Million |
| Earnings Per Share Basic | -27.97 | -31.16 | -40.40 | -74.91 | -45.84 | -65.62 |
| Earnings Per Share Diluted | -27.97 | -31.16 | -40.40 | -74.91 | -45.84 | -65.62 |
| Weighted Average Shares Outstanding | 278.58 Thousand | 261.96 Thousand | 223.51 Thousand | 177.02 Thousand | 154.83 Thousand | 115.29 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 278.58 Thousand | 261.96 Thousand | 223.51 Thousand | 177.02 Thousand | 154.83 Thousand | 115.29 Thousand |
| Gross Margin | 0.96 | 0.85 | 0.80 | -2.77 | - | - |
| EBIT Margin | -1.41 | -3.08 | -5.03 | -566.54 | - | - |
| Profit Margin | -1.50 | -3.25 | -5.58 | -576.11 | - | - |
| EBITDA | -7.29 Million | -7.72 Million | -8.03 Million | -13.04 Million | - | - |
| Earnings Before Tax Margin | -1.43 | -3.10 | -5.04 | -566.78 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.55 Million | 1.73 Million | 1.67 Million | 5.18 Million | 1.56 Million | 1.13 Million |
| Cost of Revenue | 41.47 Thousand | 92.52 Thousand | 59.02 Thousand | 201.87 Thousand | 34.9 Thousand | 57.35 Thousand |
| Gross Profit | 2.5 Million | 1.64 Million | 1.61 Million | 4.97 Million | 1.52 Million | 1.07 Million |
| Operating Expenses | 3.73 Million | 3.14 Million | 3.5 Million | 12.4 Million | 3.13 Million | 2.85 Million |
| Selling, General and Administrative Expenses | 3.73 Million | 3.13 Million | 3.48 Million | - | 3.13 Million | 2.76 Million |
| Research and Development Expenses | - | 4645.00 | 22.56 Thousand | - | - | 92.35 Thousand |
| Other Expenses | 41.47 Thousand | 92.52 Thousand | 59.02 Thousand | 201.87 Thousand | 34.9 Thousand | 57.35 Thousand |
| Cost and Expenses | 3.77 Million | 3.23 Million | 3.56 Million | 12.61 Million | 3.16 Million | 2.91 Million |
| Operating Income | -1.22 Million | -1.5 Million | -1.88 Million | -7.43 Million | -1.6 Million | -1.78 Million |
| Interest Expense | 124.65 Thousand | 124.65 Thousand | 126.02 Thousand | 500 Thousand | 126.02 Thousand | 124.65 Thousand |
| Income Tax Expense | -1.22 Million | -1.5 Million | -1.88 Million | -7.43 Million | 75.14 Thousand | -80.92 Thousand |
| Earnings before Tax | -1.26 Million | -1.57 Million | -1.98 Million | -7.79 Million | -1.69 Million | -1.86 Million |
| Net Income | -1.26 Million | -1.57 Million | -1.98 Million | -7.79 Million | -1.69 Million | -1.86 Million |
| Earnings Per Share Basic | -0.93 | -0.17 | -0.59 | - | -0.51 | -0.56 |
| Earnings Per Share Diluted | -0.93 | -0.17 | -0.59 | - | -0.51 | -0.56 |
| Weighted Average Shares Outstanding | 1.36 Million | 9.08 Million | 3.34 Million | 3.34 Million | 3.34 Million | 3.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.36 Million | 9.08 Million | 3.34 Million | 3.34 Million | 3.34 Million | 3.34 Million |
| Gross Margin | 0.98 | 0.95 | 0.96 | 0.96 | 0.98 | 0.95 |
| EBIT Margin | -0.48 | -0.87 | -1.13 | - | -1.00 | -1.54 |
| Profit Margin | -0.50 | -0.91 | -1.19 | -1.50 | -1.08 | -1.65 |
| EBITDA | -1.22 Million | -1.5 Million | -1.88 Million | - | -1.56 Million | -1.74 Million |
| Earnings Before Tax Margin | -0.48 | -0.87 | -1.13 | -1.43 | -1.03 | -1.58 |
3910
3297
SMGBF
LGDDF
GASNF
0798